Clinical Trials Directory

Trials / Completed

CompletedNCT04820231

Platelet-Rich Plasma and Hip Osteoarthritis

The Effect of Platelet-Rich Plasma Injection on Pain, Function and Quality of Life in Patients With Hip Osteoarthritis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Sisli Hamidiye Etfal Training and Research Hospital · Academic / Other
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To evaluate the effect of platelet-rich plasma (PRP) injection on pain, function and quality of life in patients with hip osteoarthritis.

Detailed description

After being informed about the study and potential risk, all patients giving written informed consent will undergo study entry. Each patient received three times intra-articuler injections of PRP under ultrasound guidance, and they were administered once a week. Baseline: Visual Analog Scale (VAS) including movement, rest and night, the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and SF-36 assessment 1st month: VAS, WOMAC and SF-36 assessment 3rd month: VAS, WOMAC and SF-36 assessment 6th month: VAS, WOMAC and SF-36 assessment

Conditions

Interventions

TypeNameDescription
OTHERintra-articular PRP injection

Timeline

Start date
2017-01-01
Primary completion
2017-07-01
Completion
2018-01-01
First posted
2021-03-29
Last updated
2021-03-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04820231. Inclusion in this directory is not an endorsement.